Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-(((3,5-difluorophenyl)acetyl)amino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-(((3,5-difluorophenyl)acetyl)amino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide
Unique ID
C529132
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C529132
Entry Term(s)
compound E (benzodiazepine)
Pharm Action
Gamma Secretase Inhibitors and Modulators
Registry Numbers
0
Heading Mapped to
*Benzodiazepinones
Frequency
18
Note
has antineoplastic activity; structure in first source
Source
J Biol Chem 2000 Nov 3;275(44):34086-91
Date of Entry
2008/05/27
Revision Date
2021/05/20
2-(((3,5-difluorophenyl)acetyl)amino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide Preferred
page delivered in 0.005s